Apoptosis in the development of the immune system

Cell Death and Differentiation

Volumn 15, Issue 2, 2008, Pages 234-242

  Opferman, J T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; CASPASE; CASPASE 2; CASPASE 9; GROWTH FACTOR; INTERLEUKIN 7; NUCLEAR RECEPTOR NOR 1; NUCLEAR RECEPTOR NUR77; PROTEIN BCL 2; PROTEIN MCL 1; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; B LYMPHOCYTE; CELL DEATH; CELL MATURATION; CELL SURVIVAL; DEGENERATIVE DISEASE; GENE DELETION; HOMEOSTASIS; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOIMMUNITY; B-LYMPHOCYTES; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASES; CYTOKINES; HUMANS; IMMUNE SYSTEM; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 38049125671     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402182     Document Type: Review

References (108)

1. Nicholson DW, Thornberry NA. Caspases: Killer proteases. Trends Biochem Sci 1997; 22: 299-306.
2. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999; 17: 781-828.
3. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305-1308.
4. Sprick MR, Weigand MA, Rieser E, Rauch CT, Juo P, Blenis J et al. FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity 2000; 12: 599-609.
5. Chinnaiyan AM, Prasad U, Shankar S, Hamstra DA, Shanaiah M, Chenevert TL et al. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci USA 2000; 97: 1754-1759.
6. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature 1998; 392: 296-300.
7. Kang TB, Ben-Moshe T, Varfolomeev EE, Pewzner-Jung Y, Yogev N, Jurewicz A et al. Caspase-8 serves both apoptotic and nonapoptotic roles. J Immunol 2004; 173: 2976-2984.
8. Salmena L, Lemmers B, Hakem A, Matysiak-Zablocki E, Murakami K, Au PY et al. Essential role for caspase 8 in T-cell homeostasis and T-cell-mediated immunity. Genes Dev 2003; 17: 883-895.
9. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1995; 14: 6136-6147.
10. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999; 400: 886-891.
11. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
12. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998; 60 619-642.
13. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996; 86: 147-157.
14. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES et al. Cytochrome c and dATP-dependent formation of Apaf-1/ caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-489.
15. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 2004; 23: 2861-2874.
16. Willis SN, Adams JM. Life in the balance: How BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005; 17: 617-625.
17. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA et al The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000; 6: 1389-1399.
18. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ et al. Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death. Science 2001; 292: 727-730.
19. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M et al. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 2000; 14: 2060-2071.
20. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, Lindsten T et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705-711.
21. Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB. BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15: 1481-1486.
22. Willis SN, Fletcher JI, Kaufmann T, van Delft MF. Chen L, Czabotar PE et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007:315: 856-859
23. Owen JJ, Jenkinson EJ. Apoptosis and T-cell repertoire selection in the thymus. Ann NY Acad Sci 1992; 663: 305-310.
24. Baird AM, Gerstein RM, Berg LJ. The role of cytokine receptor signaling in lymphocyte development. Curr Opin Immunol 1999; 11: 157-166.
25. Jung D, Giallourakis C. Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006; 24: 541-570.
26. Berg LJ, Kang J. Molecular determinants of TCR expression and selection. Curr Opin Immunol 2001; 13: 232-241.
27. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol 2006; 6: 728-740.
28. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Annu Rev Immunol 1999; 17 829-874.
29. Melchers F, ten Boekel E, Seidl T, Kong XC, Yamagami T, Onishi K et al. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells. Immunol Rev 2000; 175: 33-46.
30. Jameson SC, Hogquist KA, Bevan MJ. Positive selection of thymocytes. Annu Rev immunol 1995, 13: 93-126.
31. Milne CD, Paige CJ, IL-7: A key regulator of B lymphopoiesis. Semin Immunol 2006; 18: 20-30.
32. Lee SK, Surh CD, Role of interleukin-7 in bone and T-cell homeostasis. Immunol Rev 2005; 208: 169-180.
33. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M et al. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro- apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996; 26: 294-299.
34. von Freeden-Jeffry U, Solvason N, Howard M, Murray R. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 1997: 7: 147-154.
35. Miyazaki T, Liu ZJ, Kawahara A, Minami Y, Yamada K, Tsujimoto Y et al Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and Ick cooperate in hematopoietic cell proliferation, Cell 1995; 81: 223-231.
36. Li WQ, Jiang Q, Khaled AR, Keller JR, Durum SK. Interleukin-7 inactivates the pro-apoptotic protein Bad promoting T cell survival. J Biol Chem 2004; 279: 29160-29166.
37. Maraskovsky E, O'Reilly LA, Teepe M, Corcoran LM, Peschon JJ, Strasser A. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor- deficient mice but not in mutant rag-1 -/- mice. Cell 1997; 89 1011-1019.
38. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997; 89: 1033-1041.
39. Kondo M, Akashi K, Domen J, Sugamura K, Weissman IL. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity 1997, 7: 155-162
40. Ranger AM, Malynn BA, Korsmeyer SJ. Mouse models of cell death. Nat Genet 2001; 28: 113-118.
41. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003; 426: 671-676.
42. Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475-1486.
43. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 2006; 21: 749-760.
44. Ranger AM, Zha J, Harada H, Datta SR, Danial NN, Gilmore AP et al. Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA 2003; 100: 9324-9329.
45. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735-1738.
46. Pellegrini M, Bouillet P, Robati M, Belz GT, Davey GM, Strasser A. Loss of Bim increases T cell production and function in interleukin 7 receptor-deficient mice. J Exp Med 2004; 200: 1189-1195.
47. Jeffers JR, Pargapas E, Lee Y, Yang C, Wang J, Brennan J et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4: 321-328.
48. Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006: 203: 2939-2951.
49. Khaled AR, Li WQ, Huang J, Fry TJ, Khaled AS, Mackall CL et al. Bax deficiency partially corrects interleukin-7 receptor alpha deficiency. Immunity 2002; 17: 561-573.
50. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002; 3: 932-939.
51. Takeuchi O, Fisher J, Suh H, Harada H, Malynn BA, Korsmeyer SJ. Essential role of BAX, BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci USA 2005; 102: 11272-11277.
52. Mandal M, Borowski C, Palomero T, Ferrando AA, Oberdoerffer P, Meng F et al. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med 2005; 201: 603-614.
53. Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC et al NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity 2000; 13: 677-689.
54. 2+ mobilization and activation of NF-kappaB and NFAT. Nat Immunol 2001; 2: 403-409.
55. Lakhani SA, Masud A, Kuida K, Porter Jr GA, Booth CJ, Mehal WZ et al Caspases 3 and 7: Key mediators of mitochondrial events of apoptosis. Science 2006; 311: 847-851.
56. Villunger A, Marsden VS, Zhan Y, Erlacher M, Lew AM, Bouillet P et al Negative selection of semimature CD4(+)8(-)HSA+ thymocytes requires the BH3-only protein Bim but is independent of death receptor signaling. Proc Natl Acad Sci USA 2004; 101: 7052-7057.
57. Hara H, Takeda A, Takeuchi M, Wakeham AC, Itie A, Sasaki M et al. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes. J Immunol 2002; 168: 2288-2295.
58. Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A. Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 2004; 165: 775-780.
59. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365-371.
60. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998; 17: 706-718.
61. Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice. Nat Immunol 2003; 4: 255-260.
62. Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ. Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med 2003; 198: 491-496.
63. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036-1038.
64. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Pulhalakath H et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922-926.
65. McCarty N, Paust S, Ikizawa K, Dan I, Li X, Cantor H. Signaling by the kinase MINK is essential in the negative selection of autoreactive thymocytes. Nat Immunol 2005; 6: 65-72.
66. Siegel RM, Katsumata M, Miyashita T, Louie DC, Greene MI, Reed JC. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc Natl Acad Sci USA 1992; 89: 7003-7007.
67. Williams O, Norton T, Halligey M, Kioussis D, Brady HJ. The action of Bax and bcl-2 on T cell selection. J Exp Med 1998; 188: 1125-1133.
68. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879-888.
69. Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889-899.
70. Strasser A, Harris AW, von Boehmer H, Cory S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci USA 1994; 91: 1376-1380.
71. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 1994; 367: 281-284.
72. Woronicz JD, Calnan B, Ngo V, Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994; 367: 277-281.
73. Calnan BJ, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995; 3: 273-282.
74. Zhou T, Cheng J, Yang P, Wang Z, Liu C, Su X et al. Inhibition of Nur77/Nurr1 leads to inefficient clonal deletion of self-reactive T cells. J Exp Med 1996; 183: 1879-1892.
75. Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, Milbrandt J. Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 1995; 269: 532-535.
76. Ponnio T, Burton Q, Pereira FA, Wu DK, Conneely OM. The nuclear receptor Nor-1 is essential for proliferation of the semicircular canals of the mouse inner ear. Mol Cell Biol 2002; 22: 935-945.
77. Lin B, Kolluri SK, Lin F, Liu W, Han YH, Caox et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 2004; 116: 527-540.
78. Hanley SB, Crosbie J, Brink R, Kantor AB, Basten A, Goodnow CC. Elimination from peripheral lymphold tissues of self-reactive B ymphocyles recognizing membrane-bound antigens. Nature 1991; 353: 765-769.
79. Tiegs SL, Russell DM, Nemazee D. Receptorediting in self-reactive bone marrow B cells. J Exp Med 1993; 177: 1009-1020.
80. Rathmell JC, Goodnow CC. Effects of the Ipr mutation on elimination and inactivation of sef-reactive B cells. J Immunol 1994; 153: 2831-2842.
81. Hanley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A et al Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1999; 72: 325-335.
82. Yoshida T, Higuchi T, Hagiyama H, Strasser A, Nishiolka K, Tsubata T. Rapid B cell apoptosis induced by antigen receptor ligation does not require Fas (CD95/APO-1), the adaptor protein FADD/MORT1 or CrmA-sensitive caspases but is defective in both MRL-+/+ and MRL-Ipr/Ipr mice. Int Immunol 2000; 12: 517-526.
83. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only BcI-2 family member Bim inhibits BCR stimulation-induced apoptosis. and deletion of autoreactive B cells. J Exp Med 2003; 198: 1119-1126.
84. Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 1999; 189: 1747-4756.
85. Varfolomeev E, Kischkel F, Martin F, Seshasayee D, Wang H, Lawrence D et al. APRIL-deficient mice, have normal immune system development. Mol Cell Biol 2004: 24: 997-1006.
86. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999; 190: 1697-1710.
87. Gross JA. Dillon SR, Mudri S, Johnston J, Littau A, Roque R et al. TAC1-Ig neutralizes molecules critical for B cell development and autoimmune disease, Impaired B cell maturation in mice lacking BLyS. Immunity 2001; 15: 289-302.
88. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001; 293: 2111-2114.
89. Shu HB, Johnson H. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc Natl Acad Sci USA 2000; 97: 9156-9161.
90. von Bulow GU, Russell H, Copeland NG, Gilbert DJ, Jenkins NA, Bram RJ. Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse. Mamm Genome 2000; 11: 628-632.
91. Xu S, Lam KP. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 2001: 21: 4067-4074.
92. Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T et al. Activation and accumulation of B cells in TACI-deficient mice, Nat Immunol 2001; 2: 638-643.
93. von Bulow GU, van Deursen JM, Bram RJ. Regulation of the T-independent humoral response by TACI. Immunity 2001; 14: 573-582.
94. Thompson JS. Bixler SA, Qian F. Vora K. Scott ML, Cachero TG et al BAFF-R. a newly identified TNF receptor that specifically interacts with BAFF. Science 2001; 293: 2108-2111.
95. Yan M, Brady JR, Chan B, Lee WP, Hsu B, Harless S et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 2001; 11: 1547-1552.
96. He B, Chadburn A, Jou E, Schattner EJ, Knowles DM, Cerutti A. Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL. J Immunol 2004; 172: 3268-3279.
97. Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V et al Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood 2004; 103: 679-688.
98. Sasaki, Derudder E, Hobeika E, Pelanda R, Reth M, Rajewsky K et al Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 2006; 24: 729-739.
99. Mecklenbrauker I, Kalled SL, Leitges M, Mackay F, Tarakhovsky A, Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signalling, Nature 2004; 431: 456-461.
100. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity 1998: 8: 439-449.
101. Kabra NH, Kang C, Hsing LC, Zhang J, Winoto A. T cell-specific FADD-deficient mice: FADD is required for early T cell development. Proc Nall Acad Sci USA 2001; 98: 6307-6312.
102. Newton K, Harris AW, Strahser A. FADD/MORT1 regulates the pre-TCR checkpoint and can function as a tumour suppressor, EMBO J 2000; 19: 931-941.
103. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M et al. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr, Biol 2000; 10: 640-648.
104. Yeh WC, Itie A; Elie AJ, Ng M, Shu HB, Wakeham A et al. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000; 12: 633-642.
105. Zhang N, He YW. An essential role for c-FLIP in the efficient development of mature T lymphocytes. J Exp Med 2005; 202: 395-404.
106. Chau H, WongV, Chen NJ, Huang HL, Lin WJ, Mirtsos C et al. Cellular FLICE-Inhibitory protein is required for T cell survival and cycling. J Exp Med 2005; 202: 405-413.
107. Su H, Bidere N, Zheng L, Cubre A, Sakai K, Dale J et al. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307: 1465-1468.
108. Newton K, Kurts C, Harris AW, Strasser A. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr Biol 2001; 11: 273-276.